Related Experiment Video
Updated: Feb 5, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation
Kerstin Benz1, Karl-Friedrich Hilgers2, Christoph Daniel1
1Department of Nephropathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Germany.
Insights
Patients with chronic kidney disease (CKD) face high rates of cardiovascular complications and death. Inflammation and vascular calcification in CKD patients contribute significantly to this increased cardiovascular risk.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular complications are the leading cause of death in chronic kidney disease (CKD) patients.
- CKD patients exhibit a 3-fold higher incidence of cardiovascular disease and a 10-fold higher mortality rate compared to the general population.
- Advanced vascular calcification is a key factor in the high cardiovascular morbidity and mortality observed in CKD.
Purpose of the Study:
- To investigate the role of inflammation in the pathogenesis of vascular calcification in CKD.
- To explore the link between local vascular inflammation and the development of calcifying particles in CKD.
- To examine the phenotype of coronary atherosclerotic plaques in CKD patients.
Main Methods:
- Analysis of systemic and local (micro)inflammation in CKD patients and animal models.
- Assessment of proinflammatory and proosteogenic molecules in vascular tissues.
- Evaluation of costimulatory molecules and mast cell expression in CKD patient plaques.
Main Results:
- Increased systemic and local inflammation in CKD promotes vascular calcification.
- Early stages of CKD show upregulation of proinflammatory and proosteogenic molecules, contributing to vascular calcification.
- CKD patients exhibit increased expression of costimulatory molecules and mast cells, indicating a more inflammatory plaque phenotype.
Conclusions:
- Inflammation is a critical driver of vascular calcification and cardiovascular complications in CKD.
- Targeting inflammation may be a therapeutic strategy to reduce cardiovascular risk in CKD patients.
- CKD is associated with an inflammatory and potentially unstable phenotype of coronary atherosclerotic plaques.
Abstract:
Cardiovascular complications are extremely frequent in patients with chronic kidney disease (CKD) and death from cardiac causes is the most common cause of death in this particular population. Cardiovascular disease is approximately 3 times more frequent in patients with CKD than in other known cardiovascular risk groups and cardiovascular mortality is approximately 10-fold more frequent in patients on dialysis compared to the age- and sex-matched segments of the nonrenal population. Among other structural and functional factors advanced calcification of atherosclerotic plaques as well as of the arterial and venous media has been described as potentially relevant for this high cardiovascular morbidity and mortality. One potential explanation for this exceedingly high vascular calcification in animal models as well as in patients with CKD increased systemic and most importantly local (micro)inflammation that has been shown to favor the development of calcifying particles by multiple ways. Of note, local vascular upregulation of proinflammatory and proosteogenic molecules is already present at early stages of CKD and may thus be operative for vascular calcification. In addition, increased expression of costimulatory molecules and mast cells has also been documented in patients with CKD pointing to a more inflammatory and potentially less stable phenotype of coronary atherosclerotic plaques in CKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

